Central Nervous System Collaboration and Licensing Deals 2020-2026

Description

The definitive benchmark for central nervous system dealmaking

Central nervous system (CNS) partnering spans a wide range of deal structures across indications, modalities, and stages of development, reflecting the scientific complexity and risk profile of the space.

This report provides a comprehensive and structured analysis of 900+ CNS collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how CNS deals are structured in practice, allowing you to:

Benchmark comparable transactions with confidence
Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
Define realistic market parameters
Clear insight into how deal terms vary by stage, asset type, and partner profile
Support valuation and structuring decisions with evidence
Ground internal discussions in real transaction data rather than assumptions
Understand how leading companies approach dealmaking
Visibility into partner behaviour and recurring deal structures across a highly heterogeneous therapeutic landscape
Full visibility into deal structure and execution
Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

Rights granted and retained
Development and commercialization responsibilities
Financial structures and payment triggers
Key contractual provisions and protections
This level of transparency is critical to understanding how value, risk, and control are allocated within CNS partnerships, particularly in areas with higher development uncertainty.
Designed for real-world BD and strategy use

The report is widely used to:

Structure and benchmark live transactions
Prepare for negotiations with well-defined market context
Evaluate partnership opportunities and counterparties
Support internal strategy with robust, defensible data
What's included
900+ CNS collaboration and licensing deals
Financial terms, including upfronts, milestones, and royalties where disclosed
Fully searchable deal directory (by company, therapy, and technology)
Direct access to SEC-filed agreements and source documents
Analysis of deal trends, key transactions, and active dealmakers
A trusted, evidence-based reference for CNS dealmaking
Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how CNS partnerships are structured, negotiated, and valued.

Product Code: CP2203

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in central nervous system dealmaking

2.1. Introduction
2.2. Central nervous system partnering over the years
2.3. Central nervous system partnering by deal type
2.4. Central nervous system partnering by industry sector
2.5. Central nervous system partnering by stage of development
2.6. Central nervous system partnering by technology type
2.7. Central nervous system partnering by therapeutic indication

Chapter 3 - Financial deal terms for central nervous system partnering

3.1. Introduction
3.2. Disclosed financials terms for central nervous system partnering
3.3. Central nervous system partnering headline values
3.4. Central nervous system deal upfront payments
3.5. Central nervous system deal milestone payments
3.6. Central nervous system royalty rates

Chapter 4 - Leading central nervous system deals and dealmakers

4.1. Introduction
4.2. Most active in central nervous system partnering
4.3. List of most active dealmakers in central nervous system
4.4. Top central nervous system deals by value

Chapter 5 - Central nervous system contract document directory

5.1. Introduction
5.2. Central nervous system partnering deals where contract document available

Chapter 6 - Central nervous system dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by central nervous system therapeutic target
Deal Directory
Deal Directory - Central nervous system deals by company A-Z
Deal Directory - Central nervous system deals by technology type
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Central nervous system partnering since 2020
Figure 2: Central nervous system partnering by deal type since 2020
Figure 3: Central nervous system partnering by industry sector since 2020
Figure 4: Central nervous system partnering by stage of development since 2020
Figure 5: Central nervous system partnering by technology type since 2020
Figure 6: Central nervous system partnering by indication since 2020
Figure 7: Central nervous system deals with a headline value
Figure 8: Central nervous system deals with upfront payment values
Figure 9: Central nervous system deals with milestone payment
Figure 10: Central nervous system deals with royalty rates
Figure 11: Active central nervous system dealmaking activity since 2020
Figure 12: Top central nervous system deals by value since 2020